Cerrone Gabriele M's Form 4/A amendment
AmendedTiziana Life Sciences Ltd (TLSA) · filed Aug 7, 2026
- Accession no.
- 0001213900-26-086696
- Filed
- Aug 7, 2026, 4:15 PM ET
- Trade date
- Jun 12, 2026
- Filing delay
- 56 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jun 17, 2026
This filing lists 1 non-derivative transaction. Open-market purchases total $16.6K. It was filed 56 days after the trade.
This amendment replaces 0001213900-26-069424 (filed Jun 17, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cerrone Gabriele MCIK 0001139306 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | COMMON STOCK | PPurchaseAcquired | +15,000 | $1.11 | +$16,650 | 44,772,230 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
This amendment has no footnotes.
Remarks
This Form 4/A amends the Form 4 filed on June 17, 2026 solely to correct the transaction code associated with this open market purchase. No other reported transactions are affected by this amendment.